Meet SOPHiA GENETICS at AMP 2026

Date: November 10, 2026 - November 14, 2026
Type: In-person
Location: North America
Areas of Interest: Liquid Biopsy, Solid Tumors

SOPHiA GENETICS is thrilled to attend this year's Association for Molecular Pathology (AMP) Annual Meeting at the Seattle Convention Center!

Find us at Booth #715 to explore how SOPHiA DDM™ is advancing precision oncology across comprehensive solid tumor profiling and hematologic malignancies, with AI-powered analytics that transform complex data into actionable insights.

Check out our AMP activities:

Corporate Workshop: One Integrated Workflow from Tissue to Liquid Biopsy: Real-World Insights on MSK-IMPACT® Flex and MSK-ACCESS® powered with SOPHiA DDM™
Wednesday, November 11 – 8:00 AM – 8:50 AM
Skagit 5, Lower Level, Arch at 800 Pike

Speakers:
Andrew Fellowes – Lead Scientist, Molecular Diagnostic Development, Peter MacCallum Cancer Center
Lina Li, Product Marketing Director – Solid Tumors, SOPHiA GENETICS

Add to Calendar

Corporate Workshop: Scaling Decentralized Pan-Cancer Liquid Biopsy: Multicentric Validation of MSK-ACCESS® powered with SOPHiA DDM™
Wednesday, November 11 – 9:00 AM – 9:50 AM
Skagit 5, Lower Level, Arch at 800 Pike

Speaker:
Florian Klemm, Technical Product Management Expert, SOPHiA GENETICS

Add to Calendar

Blood Cancer Showcase: The Next Frontier in Blood Cancer Genomics
Wednesday, November 11 – 6:30 PM
Venue TBD, Seattle

Join SOPHiA GENETICS for an evening, dedicated to advances in blood cancer, diagnostics, and precision oncology.

Agenda:

Brandon Bullough - Product Marketing Director, Blood Cancers, SOPHiA GENETICS
Gang Zheng, M.D., Ph.D. - Co-director Clinical Genomics Laboratory, Professor of Laboratory Medicine and Pathology, Mayo Clinic
Todd C. Knepper, PharmD - Associate Member in Precision Oncology, Department of Pathology, Moffitt Cancer Center

Poster Presentations

Saturday, November 14 – 9:15 – 10:15 AM

ST005: Multicentric Validation of MSK-ACCESS® powered with SOPHiA DDM™ for Pan-Cancer Liquid Biopsy Testing in Decentralized Molecular Pathology

Presenter: Florian Klemm, Technical Product Management Expert, SOPHiA GENETICS

Co-authors: Fuad Mohammad, Jonathan Bieler, Frederic Michaud, Anjali Anjali, Alex Charles Tuck, Saraj Figarol, Anne Pradines, Laura Keller, Maryline Allegra, Guylene Rignol, Paul Hofman, Caroline Lacoux, Laurie Canetti, Emeline Jorge, Frédérique Penault-Llorca, Marie-Celeste Ferreira, Rochelle Awuku, Alasdair Heasman, Gareth Gerrard, Persephone Du-Parcq, Gaëlle Lescuyer, Marie Piecyk, Lea Payen, Tessara Baldi, Anita Bowman, Rose Brannon, Michael Berger, Zhenyu Xu

ST017: MSK-IMPACT® Flex powered with SOPHiA DDM™ Enables Accurate Comprehensive Genomic Profiling of Solid Tumors via Element AVITI24 Platform

Presenter: Slawomir Kubik, Head of Technical Product Management – Oncology, SOPHiA GENETICS

Co-authors: Christian Pozzorini, Alexis Bachmann, Gregoire Andre, Frederic Michaud, Elia Magrinelli, Tommaso Coletta, Yvan Wenger, Adrian Willig, Kevin Green, Benjamin Krajacich, Marina McCowin, Kelly Wiseman, Junhua Zhao, Zhenyu Xu

Plan your AMP visit

Whether you're working in solid tumor profiling, liquid biopsy, or hematologic malignancies, we'd love to connect and learn more about the challenges your laboratory is working to solve.

Meeting slots at AMP fill quickly. Book time with our team before you arrive in Seattle.

See you there! 🧬

Book a Meeting

Register Now

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Company(Required)

Job Title(Required)

Area of Interest(Required)

Email(Required)

Phone

Country(Required)

Select US State(Required)

Privacy Policy(Required)

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

3rd Party Opt-In

I agree that SOPHiA GENETICS may share my webinar registration details with 3rd parties, and that I may receive marketing communications from these 3rd parties. I understand that I can withdraw my consent at any time.

Job Title/Industry(Required)

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are those of the speakers and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services